Jobs · Business Development · Pennsylvania

Charles W.M. Roberts – Candidate for Board of Directors of AACR

OncoDaily GU · Lycoming Career and Technology Center, PA · 2 days ago
Business DevelopmentVolunteer

About the role

The voting for the 2025 AACR Annual Election is now open, where members will vote for the next President-Elect, Treasurer, five Board Members, and four members of the Nominating Committee. This year, Charles W.M. Roberts, MD, PhD is a candidate for the Board of Directors of AACR.

Responsibilities

  • Serves as a member of the Steering Committee for the Hematologic Malignancies Working Group
  • Co-chairs the Special Conferences Committee
  • Serves as a member of the Annual Meeting Program Committee (2016-2017 and 2023-2024)
  • Serves as a member of the Annual Meeting Education Committee (2016-2017)
  • Serves as a member of the Scientific Review Committee for Basic Cancer Research Grants (2014-2016)
  • Co-chairs the Special Conferences Committee
  • Serves as a member of the Pediatric Cancer Working Group Steering Committee (2020-2023)
  • Contributes to AACR publications as a scientific editor for Cancer Discovery (since 2020) and as a member of the editorial board for Molecular Cancer Research (since 2015)

Requirements

Dr. Charles W. M. Roberts is highly engaged with AACR through numerous leadership roles and contributions. He has a strong background in pediatric oncology, molecular oncology, and epigenetics, with extensive experience in research, teaching, and clinical practice.

Qualifications

  • Cancer Center Director and Executive Vice President at St. Jude Comprehensive Cancer Center
  • Lillian R. Cannon Comprehensive Cancer Center Director Endowed Chair
  • Attending physician in the Department of Oncology at St. Jude Children’s Research Hospital
  • Professor in the Department of Pathology and Laboratory Medicine at the University of Tennessee Health Science Center
  • Formerly held key positions at Dana-Farber Cancer Institute, including Deputy Chief Scientific Officer (2015), Scientific Director, and Co-Director of the Pediatric Solid Tumor Disease Center (2007-2015)
  • Contributed to the development of Tazemetostat, a first-in-class targeted epigenetic regulator

Skills

  • Research in pediatric oncology and epigenetics
  • Leadership roles in AACR
  • Expertise in molecular and epigenetic mechanisms of cancer
  • Experience in translational and clinical research

Benefits

Not specified.

Pay

Not specified.

Schedule

Not specified.

Similar jobs